These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22020296)
1. Anti-idiotypic single chain mimicking CA125 linked with tuftsin provides protective immunity against ovarian cancer in mice. Yuan W; Xia G; Zhao C; Sui C; Ma J Mol Med Rep; 2012 Feb; 5(2):388-94. PubMed ID: 22020296 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer. Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653 [TBL] [Abstract][Full Text] [Related]
3. The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice. Cui H; Chang XH; Liu B; Feng J; Li Y; Ye X; Cao SJ; Fu TY; Yao Y; Li HQ; Qian HN Int J Gynecol Cancer; 2004; 14(2):234-41. PubMed ID: 15086722 [TBL] [Abstract][Full Text] [Related]
4. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique. Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128 [TBL] [Abstract][Full Text] [Related]
5. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125. Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126 [TBL] [Abstract][Full Text] [Related]
6. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response. Ma J; Zhou L; Wang D Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report. Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787 [TBL] [Abstract][Full Text] [Related]
8. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125. Li AD; Li Z; Wang YH; Zhang YM; Ma J Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051 [TBL] [Abstract][Full Text] [Related]
9. Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses. Ma J; Luo D; Kwon GS; Samuel J; Noujaim AA; Madiyalakan R J Pharm Sci; 1998 Nov; 87(11):1375-8. PubMed ID: 9811493 [TBL] [Abstract][Full Text] [Related]
10. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres. Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874 [TBL] [Abstract][Full Text] [Related]
11. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer]. Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911 [TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice. Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995 [TBL] [Abstract][Full Text] [Related]
13. Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma. Cheng H; Ye X; Chang X; Ma R; Cong X; Niu Y; Zhang M; Liu K; Cui H; Sang J Med Oncol; 2015 Apr; 32(4):130. PubMed ID: 25794492 [TBL] [Abstract][Full Text] [Related]
14. Single chain antibody vaccination in mice against human ovarian cancer enhanced by microspheres and cytokines. Ma J; Li Z; Luo D J Drug Target; 2003 Apr; 11(3):169-76. PubMed ID: 14577973 [TBL] [Abstract][Full Text] [Related]
15. Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin. Gao Y; Su Q; Yi Y; Jia Z; Wang H; Lu X; Qiu F; Bi S PLoS One; 2015; 10(4):e0123400. PubMed ID: 25875115 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice. Ladjemi MZ; Chardes T; Corgnac S; Garambois V; Morisseau S; Robert B; Bascoul-Mollevi C; Ait Arsa I; Jacot W; Pouget JP; Pelegrin A; Navarro-Teulon I Breast Cancer Res; 2011 Feb; 13(1):R17. PubMed ID: 21294885 [TBL] [Abstract][Full Text] [Related]
17. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer. Schlebusch H; Wagner U; Grünn U; Schultes B Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775 [TBL] [Abstract][Full Text] [Related]
18. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)]. Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096 [TBL] [Abstract][Full Text] [Related]
20. [In vitro study of 6B11GM to induce cellular immunity in patients with ovarian carcinoma]. Yang F; Qian H; Feng J Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):660-3. PubMed ID: 11479947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]